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Abstract
Objectives: Incidental findings in neuroimaging occur in 3% of volunteers. Most data come from young subjects. Data on
their occurrence in older subjects and their medical, lifestyle and financial consequences are lacking. We determined the
prevalence and medical consequences of incidental findings found in community-dwelling older subjects on brain magnetic
resonance imaging.
Design: Prospective cohort observational study.
Setting: Single centre study with input from secondary care.
Participants: Lothian Birth Cohort 1936, a study of cognitive ageing.
Main Outcome Measures: Incidental findings identified by two consultant neuroradiologists on structural brain magnetic
resonance imaging at age 73 years; resulting medical referrals and interventions.
Primary and Secondary Outcome Measures: Prevalence of incidental findings by individual categories: neoplasms, cysts,
vascular lesions, developmental, ear, nose or throat anomalies, by intra- and extracranial location; visual rating of white
matter hyperintensities and brain atrophy.
Results: There were 281 incidental findings in 223 (32%) of 700 subjects, including 14 intra- or extracranial neoplasms (2%),
15 intracranial vascular anomalies (2%), and 137 infarcts or haemorrhages (20%). Additionally, 153 had moderate/severe
deep white matter hyperintensities (22%) and 176 had cerebral atrophy at, or above, the upper limit of normal (25%)
compared with a normative population template. The incidental findings were unrelated to white matter hyperintensities or
atrophy; about a third of subjects had both incidental findings and moderate or severe WMH and a quarter had incidental
findings and atrophy. The incidental findings resulted in one urgent and nine non-urgent referrals for further medical
assessment, but ultimately in no new treatments.
Conclusions: In community-dwelling older subjects, incidental findings, including white matter hyperintensities and
atrophy, were common. However, many findings were not of medical importance and, in this age group, most did not result
in further assessment and none in change of treatment.
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Introduction
In neuroimaging research, incidental findings are defined as
‘‘apparently asymptomatic intracranial abnormalities that are
clinically significant because of their potential to cause symptoms
or need to be treated’’ [1,2]. They are unknown to the subject and
unrelated to the purpose of the imaging. They may cause anxiety,
and potentially have medical, lifestyle or financial consequences
[3]. They are an increasing problem in imaging research, in health
screening and in clinical practice.
Most data on the frequency of incidental findings in neuroim-
aging come from young subjects [4]. In a meta-analysis of 16
neuroimaging studies including 19,559 volunteers with mean ages
from 11 to 63 years examined with MRI, the overall prevalence of
incidental findings was 3%, giving a ‘‘number needed to scan’’ of
37 to detect any incidental finding [4]. The incidence increased
with age and magnet field strength. The results were of limited
relevance to the ageing population, however, as few subjects were
aged over 70 years, there existed between-study heterogeneity for
some findings, and many findings were poorly described.
There is no systematic assessment of the medical or non-medical
consequences of incidental findings, only anecdotal or retrospec-
tive reports [5], with no reliable data on subsequent treatment or
lifestyle impact. Anecdotal reports indicate that incidental findings
may cause considerable anxiety to the individual [6,7], plus
nuisance to individuals and medical services [7]. If arising during
investigation for another illness, they may deflect attention away
from important primary health findings [7,8]. In research or
commercial screening they may inflate health care costs and
workload of already stretched medical services [9].
People are living longer. By 2050, 40% of populations in many
Western countries will be over 50 and 25% over 65. Promotion of
lifelong health and wellbeing is a government research priority in
which imaging of brain structure and function plays a major role
[10]. The paucity of data on the frequency, medical and lifestyle
implications of incidental findings in neuroimaging in older people
makes it difficult to inform subjects accurately about participating
in research, particularly at ages when factors such as access to
travel and other types of health-related insurance may already be
difficult. Companies offering scanning as part of ‘lifestyle health
screening’ often target an older clientele [11].
We examined brain MRI data acquired from community-
dwelling older subjects during research on cognitive ageing to
determine the age-related prevalence and medical consequences of
key incidental findings.
Methods
Subjects
Subjects were participants of the Lothian Birth Cohort 1936
(LBC1936), a longitudinal study of cognitive ageing. This cohort
includes 1091 community-dwelling adults most of whom complet-
ed the Moray House Test (MHT) of verbal reasoning as part of the
Scottish Mental Survey 1947 (SMS1947) at a mean age of 11 years
[12]. All of the LBC1936 participants were born in 1936 and most
resided in the Edinburgh area of Scotland when recruited at age
70 years. In the first wave of the study, the 1091 LBC 1936
subjects were retested on the MHT in addition to other detailed
cognitive, sociodemographic and physical assessments. Around
three years later, at about age 73 years, all surviving members who
were non-demented were invited for re-testing and 866 members
of the cohort returned for re-testing (second wave) this time
including detailed structural brain MRI [13]. Subjects with
possible dementia (Mini Mental State Exam (MMSE) scores
,24 [14]) were excluded. The study was approved by the Lothian
(REC 07/MRE00/58) and Scottish Multicentre (MREC/01/0/
56) Research Ethics Committees and all subjects gave written,
informed consent.
Neuroimaging
Participants underwent brain MRI using a GE Signa Horizon
1.5 T HDxt clinical scanner (General Electric, Milwaukee, USA)
equipped with a self-shielding gradient set (33 mT m21 maximum
gradient strength) and manufacturer supplied 8-channel phased-
array head coil. The examination comprised whole brain T2-, T2*-
and FLAIR-weighted axial sequences, a high-resolution T1-
weighted volume scan acquired in the coronal plane from the
upper neck to vertex, and diffusion tensor (DT), magnetization
transfer (MT) and T1-mapping brain MRI sequences [13].
Radiological Reporting
The structural MRI data (axial T2, T2*, FLAIR, coronal T1)
were transferred to the Scottish National Picture Archiving and
Communications System (PACS) and reported by a consultant
neuroradiologist (JMW) blind to all information about the subjects
except for their participation in the study. A second neuroradi-
ologist (ZM) also evaluated the images independently. Information
from the two sources was combined and any discrepancies
discussed. All lesions were identified according to standard clinical
neuroradiological practice based on their typical appearances, e.g.
of neoplasms or arteriovenous malformations, aneurysms, infarcts
(cortical, subcortical or posterior fossa) or haemorrhages, arach-
noid cysts, etc. White matter hyperintensities (WMH) were scored
using the Fazekas scale, a well validated visual rating method
which codes the deep and periventricular lesions separately, each
on a scale of zero to three [15]. WMH were dichotomised into
none/mild (Fazekas 0, 1) and moderate/severe (Fazekas 2, 3).
Brain atrophy was coded in six categories by comparison with a
validated visual template derived from normal subjects aged
between 65–70 and 75–80 years in our population [16], which
codes superficial and deep atrophy separately on a six point scale
(‘5’ represents the upper 95% confidence interval and ‘69 indicates
brain volume loss in excess of normal for age).
Medical Assessment
The radiological reports were reviewed by a consultant
geriatrician (JMS) with access to the subjects’ hospital medical
records, the subject’s General Practitioner and the subject
themselves and who could act on any findings. Findings were
discussed by the radiologists and geriatrician and other relevant
clinicians as necessary, including neurologists and stroke physi-
cians, and referred to the subject’s family doctor when appropri-
ate.
Analysis
Any structural incidental findings were categorised into pre-
specified intra- or extra-cranial pathological categories: neoplasms,
cysts, vessel abnormalities, infarcts or haemorrhages, ENT
problems, structural variants, and others. The WMH and atrophy
ratings initially were analysed separately from the counting of
structural incidental findings as WMH and atrophy are common
accompaniments of ageing for which at present the causes are
poorly understood and there is no proven treatment. Additionally,
the WMH [15] and atrophy [16] quantification were performed
using established scales detailed above to improve consistency and
specificity rather than using the verbal descriptions of WMH and
atrophy in radiological reports. We then examined the proportion
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of subjects with incidental findings by WMH score (summed
Fazekas score of 0 to 6) and by deep and superficial atrophy scores
at or above the upper limit of normal for age according to our
population normal template. The number of participants referred
for further assessment or treatment and any resulting action
(urgent, non-urgent, none) was assessed by cross-referencing with
the case notes and hospital records.
Results
Of the 741 participants who agreed to undergo brain MRI, 700
(mean age 72.5 years; SD 1.5 years; 368 male) provided usable
structural MRI images. Subjects unable to provide MRI data
included 29 with claustrophobia, four whose physical size or shape
precluded lying in the scanner, four who were too unwell to be
scanned, three with dental artefact problems, and one with a
stapedectomy (contraindication to MRI).
Of the 700 subjects with usable brain images, 223 (32%, 95%
CI 28–35%), of whom 89 were female and 134 were male, had
281 incidental findings (Table 1); 172 subjects had a single finding,
44 had two, and seven had three. Examples of incidental findings
can be seen in Figure 1.
There were 14 intra- or extracranial tumours (2% of the 700
subjects, 95% CI 1.1–3.3%), 15 developmental or acquired cysts
(2.4%, 95% CI 1.2–3.5%), 14 vascular abnormalities (2%, 95% CI
1.1–3.3%), 76 varied ENT problems (10.9%, 95% CI 8.6–13.2%),
and 16 other varied findings including other developmental
variants (2.3%, 95% CI 1.3–3.4%). Eighty-six subjects had one or
more infarcts most of which were very small and included lacunes
(12%, 95% CI 10–15%), 39 subjects had one or more
microhaemorrhages (6%, 95% CI 4–8%), and seven subjects
had one or more old primary haematomas all small (1%, 95% CI
0.4–2%: further details in Table 2).
Moderate periventricular WMH were present in 184/700
(26%) and deep WMH in 130/700 (18%,) and severe periven-
tricular WMH were present in 46/700 (6%) and deep WMH in
23/700 (3%), Table 3; 129/70 (18%) had deep and 149/700
(21%) had superficial atrophy at the upper limit of normal for age;
45/70 (6%) had deep and 27/700 (4%) had superficial atrophy
above the upper limit of normal for age (Table 4). There was no
association between incidental findings and WMH or atrophy
scores (Table 5), the number of subjects with incidental findings
and moderate to severe WMH scores (83/223, 37%) or atrophy
above the upper limit of normal (61/223, 27%, with deep atrophy)
being the same as in those without incidental findings (35% and
23% respectively).
Amongst the structural findings, 18 (i.e., in 2.6% of the 700
participants) could be regarded as of potential health importance
(tumours including salivary adenomas, aneurysms, subdural
hygromas), whereas in this age group the arachnoid cysts and
cavernous angiomas would generally not be. Similarly, asymp-
tomatic infarcts, small haematomas, microbleeds, and other
vascular lesions would also generally not result in clinical referral.
The findings lead to ten referrals (3 male, 7 female) by the study
geriatrician for further specialist medical assessment (1.5% of the
700, or 4.4% of the 223 who had a structural incidental finding), of
which one was referred urgently (giant middle cerebral artery
aneurysm) and nine non-urgently (two pituitary tumours, two
salivary adenomas, one left middle cerebral artery aneurysm, one
meningioma, one cerebellar tumour, one arachnoid/cystic neo-
plasm and one mastoid problem). The remaining 271 findings
(96%) in 213 subjects (96%), including the remaining 8/18
findings that could be regarded as of potential health importance,
were judged to require no further action.
Amongst the ten subjects referred for further medical assessment
by the geriatrician, the one subject who was referred urgently
because of a giant middle cerebral aneurysm had a cerebral
angiogram which confirmed the MRI findings. However, this
subject was completely asymptomatic and declined further
treatment. The other patient with a left middle cerebral artery
aneurysm underwent MR angiography that confirmed the
aneurysm but this was considered low risk for bleeding based on
size and medical risk factors so no further action was taken. One of
the five meningiomas was referred for a further MRI with contrast
which was performed 6 months after the index scan and showed
no change. It was decided simply to observe the tumour thereafter.
Of the two suspected pituitary tumours, one underwent detailed
contrast-enhanced MRI which failed to confirm a tumour. The
other had had no further imaging by the end of the present study
period due to requiring treatment for diverticular disease which
was deemed to be more urgent as there was no evidence of a visual
field defect or hormonal imbalance on blood testing that could be
attributed to the pituitary tumour. The two salivary adenomas and
the subject with the mastoid abnormality were referred for further
imaging; the salivary adenomas were deemed to be slow growing
pleiomorphic ademomas that were too small to merit surgical
removal and were kept under review; similarly the mastoid lesion
was deemed to be longstanding and not requiring active
intervention. The patient with the cerebellar tumour underwent
further imaging and the lesion was deemed to be benign and
thereafter was simply kept under review. The one arachnoid/
cystic neoplasm was confirmed to be an arachnoid cyst after
further imaging, ie a longstanding static developmental anomaly,
that required no further action.
Of the remaining 8/18 findings that were of potential health
importance, the remaining three aneurysms were all deemed too
small for treatment, so no further action was taken. The other four
meningiomas were small and required no follow up. One subdural
hygroma was not associated with any symptoms, the subject was
not on any drugs that would increase the risk of bleeding and the
hygroma was not displacing the brain; therefore no further action
was taken.
Discussion
Incidental findings on neuroimaging, excluding WMH and
cerebral atrophy, are common (32% of 700 participants) in older
people, but most were clinically non-significant and did not result
in, or require any, further medical action. This proportion with
incidental findings is much higher than the summary estimate
from a meta-analysis of all previous neuroimaging studies (3%)
most of which studies included subjects who were much younger
[4]. The prevalence of specific lesions such as neoplasms (2%) is
similar. The prevalence of stroke lesions (20%) was higher. The
higher overall prevalence may reflect the different categorisation of
findings in previous studies as well as our inclusion of head and
neck abnormalities, the older age of our subjects and our use of
high definition scans. Adding in the proportion of subjects with
incidental findings and moderate or severe WMH (about a third)
or atrophy (about a quarter) still shows that many subjects in this
age category have structural or aging related findings on brain
imaging.
Most of the findings in the present study had little clinical
consequence but could have generated a substantial volume of
work, anxiety and non-medical consequences without neuroradi-
ology and a physician geriatrician to avoid over-interpretation of
minor abnormalities. At present, asymptomatic cerebrovascular
lesions (infarcts, haemorrhages, lacunes, WMH, microbleeds) do
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Table 1. Total number and type of incidental findings in 223 subjects.
Lesion Lesion type Total* Urgent action Routine action No action
Neoplasms
Intracranial
Menigiomas+ 5 1 4
Pituitary+ 2 2 0
Cerebellar tumour+ 1 1 0
Arachnoid/cystic neoplasm+ 1 1 0
Enlarged choroid plexus 1 1
Extracranial
Salivary adenoma+ 3 2 1
Lipoma on neck 1 1
TOTAL 14 7 7
Cysts1
Arachnoid cysts 10 10
Pituitary cysts 1 1
Other cysts
ENT related 1 1
CSF cyst 1 1
Choroidal fissure cyst 1 1
Soft tissue cyst 1 1
TOTAL 15 15
Vascular-related abnormalities (except stroke lesions – see below)
Aneurysm+ 5 1 1 3
Cavernous haemangioma 3 3
Subdural hygroma+ 1 1
Occluded ICA 2 2
Venous angioma 2 2
Basal arterial ectasia 1 1
TOTAL 14 1 1 12
Stroke Lesions (see Table 2 for further detail)
Old infarction 72 72
Old haemorrhage 7 7
Micro haemorrhage 39 39
Lacunes 14 14
Superficial siderosis 1 1
Infarct-related cerebromalacia 2 2
Central pontine hyperintensity 1 1
Increased iron deposition – no micro
haemorrhage
1 1
TOTAL 137 137
ENT problems
Sinus problems 62 62
Mastoid problems+ 6 1 5
Maxillary polyps 6 6
ENT developmental 2 2
TOTAL 76 1 75
Structural variants
Asymmetry of cerebral hemispheres 2 2
Left temporal atrophy 1 1
Normal variant septum pellucidum 4 4
Chiari I malformation 1 1
Incidental Findings in Perspective
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Table 1. Cont.
Lesion Lesion type Total* Urgent action Routine action No action
Calcification focal iron deposits 1 1
Developmental variation in sulcation of
cerebellum
1 1
Atrophic cerebellum 1 1
Calcifications 6 6
TOTAL 17 17
Others
Congenital arch of C1 vestigial 1 1
Eye problems 2 2
Previous Surgery 2 2
Artefact 3 3
TOTAL 8 8
TOTAL 281 1 9 271
*172 had one, 44 with two and seven with three findings (total 281 findings).
+considered of potential health consequence;
1note several of these if large or if confused with other pathologies could also be considered ‘of health consequence’.
doi:10.1371/journal.pone.0071467.t001
Figure 1. Examples of incidental findings in the LBC1936: (a) pituitary adenoma, (b) giant middle cerebral artery aneurysm, (c)
Lhermitte-Duclos disease and (d) pleomorphic salivary adenoma.
doi:10.1371/journal.pone.0071467.g001
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not result in immediate medical referral or interventions. In this
age group, many subjects are already taking preventive or other
medicine prescribed for hypertension or other vascular disease, so
no additional action was deemed necessary. This would not apply
in a younger population. Of the few findings with potential for
greater current clinical health impact (tumours, aneurysms),
several were simply monitored with further imaging, and others
were not investigated further as the subject was asymptomatic and
there was no indication. The patient with the giant aneurysm that
resulted in urgent assessment declined further treatment. Again, in
a younger population, where tumours and aneurysms may be
more aggressive, these findings could have resulted in more active
medical intervention. As the present study population are part of a
longitudinal cohort study, they will be reviewed every few years
and this also may increase the tendency to ‘keep findings under
review’ rather than to intervene more aggressively. Regardless,
sensitive handling of potentially anxiety provoking findings is
important to avoid causing undue distress, unjustifiably inflating
the research, clinical workload and costs, and contributing
unnecessarily to adverse medical and potential non-medical
consequences.
About a quarter of subjects had moderate (26% periventricular
and 18% deep) or severe (6% periventricular and 3% deep) WMH
and a fifth of subjects had brain atrophy at (18% deep, 21%
superficial) or above (6% deep, 4% superficial) the upper limit of
normal for age as judged against an age-relevant normal template
[16], as is common in this age group. We distinguished these
features from the structural incidental findings as WMH and
atrophy are best assessed using structured rating scales rather than
with free text as in a standard radiological report. However the
rating was by the same neuroradiologists. Loss of brain tissue is
associated with advancing age and dementia, although all subjects
had cognitive function tests that excluded dementia as a
requirement for participation in the study. About a third of
subjects had at least one incidental finding and moderate to severe
WMH, and about a fifth of subjects have at least one incidental
finding and atrophy above the upper limit of normal for age
(Table 5). At present there is no specific treatment to avoid
atrophy or prevent or reduce WMH and therefore no specific
action was taken as a consequence of these findings. Clearly that
would change should a treatment become available. The subjects’
vascular risk factors were assessed as part of the study and subjects
with abnormal results (eg elevated blood pressure not already
known about) were notified to the family doctor.
The study has limitations. Our results may not extrapolate
directly to the medical consequences of incidental findings in
younger people where some lesions may lead to more active
intervention. The prevalence of WMH and atrophy would not
apply in younger people. We did not obtain information on any
non-medical consequences of the incidental findings such as
financial, emotional, lifestyle consequences. The study is longitu-
dinal and this may have lead to an expectation that any lesion
progression could be assessed at follow-up imaging, which may
have diminished the number of referrals for further assessment.
Our study has strengths. It is large (700 subjects). The structural
sequences were of high quality and similar to those used for clinical
MRI and all scans were examined by consultant neuroradiologists
using a high quality clinical image viewing system. Both of these
features may have increased the detection rate compared with, for
example, functional MRI research, where typically few images
with diagnostic relevance are obtained. We included head and
neck abnormalities as these structures are commonly covered by
brain volume images. We also provided information on medical
impacts.
Three other studies examined incidental findings in people aged
over 60. Vernooij et al. [17] examined 2000 people, mean age
63.3 years (range 45.7–96.7) in the Rotterdam Scan Study but did
not provide a ‘‘per subject incidental finding rate’’ (only rate per
type of finding): our rates for meningiomas, pituitary adenomas
Table 2. Number of subjects with several of the same type of
finding within the stroke lesion section of Table 1.
Category Subcategory Number of subjects
Old infarction
Total with one or more 72
With 2 16
With 3 4
With 4 1
With several 4
Lacunes
Total with one or more 14
With 2 1
With several 7
Micro haemorrhage
Total with one or more 39
With 2 4
With 3 4
With several 8
doi:10.1371/journal.pone.0071467.t002
Table 3. The proportion of subjects by Fazekas visual rating
score.
Scores Percentage of subjects
Periventricular Deep white matter
0 25 (3.2%) 109 (15.5%)
1 445 (64.2%) 438 (63.2%)
2 184 (26.3%) 130 (18.4%)
3 46 (6.3%) 23 (2.9%)
doi:10.1371/journal.pone.0071467.t003
Table 4. The proportion of subjects with each atrophy visual
rating scores.
Atrophy scores Percentage of subjects
Deep atrophy Superficial atrophy
1 50 (7.0%) 46 (6.4%)
2 88 (12.4%) 92 (13.0%)
3 219 (31.5%) 212 (30.5%)
4 170 (24.4%) 175 (25.1%)
5 129 (18.4%) 149 (21.3%)
6 45 (6.3%) 27 (3.7%)`
doi:10.1371/journal.pone.0071467.t004
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and arachnoid cysts were similar, but we found more aneurysms and
infarcts, possibly because our subjects were about 10 years older. Yue
et al [18]. imaged 3672 subjects aged over 65 years in the
Cardiovascular Health Study but only reported on potentially
clinically serious lesions; therefore, only meningiomas, aneurysms
and pituitary adenomas can be compared with the current study. Yue
[18] found fewer of these lesions in 3672 subjects aged over 65 in the
Cardiovascular Health Study than either Vernooij et al. or the
present study, although differences in scanning protocols, use of a
very low field strength scanner at one center (0.35 Tesla) with low
image resolution, and inclusion of less extracranial tissue in the head
image, may partly explain these differences [4]. Yue et al considered
meningiomas (19, of which eight were larger than 2.5 cm diameter),
aneurysms (4, of which one was giant), cavernous malformations (5,
which were multiple in one subject), subdural collections (2), vascular
stenosis (8), various other tumours including pituitary tumours (10),
extracranial (8) and other miscellaneous lesions (8) as meriting
‘immediate’ or ‘urgent’ medical alerts, a total of 64/3672 subjects
affected or 1.74%. Some of these (eg the largest meningioma and the
giant aneurysm) were known to the subjects prior to scanning, so
were not truly ‘incidental’. The proportion is similar to the proportion
of our subjects (18/700, 2.6%) with these lesion types, although if we
also include the arterial occlusions, cavernous malformations and
other intra- and extracranial lumps that we did not consider to
require further action (but Yue et al did), then the proportion of these
lesion types rises to 30/700 (4.3%) in our population. The only study
that did provide systematic information onmedical consequences was
retrospective and based on older technology (published in 1999 but
the study occurred between 1996 and 1997): 18% of 1000 healthy
volunteers aged 3–83 years participating in various research projects
had an abnormal scan, of which 15% were not referred, 2% were
referred for routine assessment and 1% were referred for urgent
assessment [5]. One study of 206 young healthy volunteers published
since the completion of the systematic review found incidental
abnormalities in 19% (of which about half were of potential clinical
relevance), but provided no data on the impact or consequences of
the findings themselves [19].
‘Incidentalomas’ are an increasing, but not new problem with
greater use of MRI for research and in the public and private
health care sectors [8,20]. Volunteers in research are essential.
There is little research assessing subjects’ own awareness of
potential incidental findings or their management [3,21], although
most potential research volunteers with [21] or without [22]
personal experience of research imaging indicate wished to be
informed of incidental findings that might have likely health
consequences. Much neuroimaging research, especially that
involving advanced imaging like functional MRI, is conducted
by researchers without clinical training in how to interpret MRI
data [23,24]. Incidental findings may be even more common in
body imaging, although even fewer data are available than for
brain imaging [25]. Following widespread consultation amongst
imaging research centres, professional organisations, research
funding agencies, ethicists and lay people (including debate at
the UK Biobank Ethics and Governance Council [20]) the UK
now has published guidance on minimum standards for the
‘‘Management of incidental findings detection during research imaging’’
(http://www.rcr.ac.uk/docs/radiology/pdf/BFCR(11)8_Ethics.
pdf) [3], and a recent report of volunteers’ opinions [22].
Volunteers’ opinions indicate the need for sensitive, proportionate
and effective mechanisms for the routine management of
incidental findings to avoid undue anxiety, particularly when
any incidental finding can occur in such a large proportion (a
third) of the volunteers.
The impact of incidental findings on employment, health, travel
or life insurance, quality of life and medical costs is currently
unknown. Similar problems regarding what to do about incidental
findings in research using genetic and laboratory techniques are
now being recognised [9,20]. Future studies should focus on
determining the medical and associated implications [7], including
of treatment and outcome, of incidental findings in brain and body
imaging research at all ages and in particular the non-medical
implications and their impact on volunteers.
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4 24 (10.9%) 45 (9.7%) 69 (10.1%) 59 (26.7%) 108 (23.3%) 167 (24.4%) 59 (26.7%) 113 (24.4%) 172 (25.1%)
5 8 (3.6%) 20 (4.2%) 28 (4.1%) 41 (18.6%) 85 (18.3%) 126 (18.4%) 56 (25.3%) 90 (19.4%) 146 (21.3%)
6 4 (1.8%) 9 (1.9%) 13 (1.9%) 20 (9.0%) 23 (5.0%) 43 (6.3%) 12 (5.4%) 13 (2.8%) 25 (3.6%)
Bold indicates WMH scores consistent with moderate to severe WMH and atrophy at or above the upper limit of normal for age. The scale indicates a) the summed deep
(0–3) and periventricular (0–3) Fazekas scores = total WMH score of 0–6, and b) the atrophy scores where 1 =,25th centile, 2 = 25–50th centile, 3 = 50–75th centile,
4 = 75–95th centile, 5 = just above 95th centile and 6= considerably above the 95th centile for age.
doi:10.1371/journal.pone.0071467.t005
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